News
-
Advancing Orphan Disease Treatment: The Promise of In Silico Clinical Trials
In silico clinical trials offer a faster, cost-effective alternative for developing treatments for rare diseases, often overlooked due to low financial returns. A recent study on Mycobacterium avium complex (MAC) lung disease showcased the potential of virtual trials, predicting how a widely available antibiotic would be a better alternative to the current treatment.
-Read more-
-
Join the new VPHi Young Scientists Committee!
The call for participation for the new VPHi Young Scientists Committee is now open! We are looking for motivated PhD students and postdocs up to 2 year after obtaining their PhD with interest in in silico medicine research willing to actively participate in the life of the community. Application deadline: 15 Nov 2024.
-Read more-
-
In the literature: Summer 2024 highlights
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
-Read more-
-
EuroHPC JU in the starting blocks for creating AI Factories
Member States agree to launch AI Factories under the EuroHPC JU with a rolling call for proposals coming soon.
-Read more-
-
Second report on the State of the Digital Decade calls for strengthened collective action to propel the EU's digital transformation
The Commission published the second report on the State of the Digital Decade, providing a comprehensive overview of the progress made in the quest to achieve the digital objectives and targets set for 2030 by the Digital Decade Policy Programme (DDPP).
-Read more-
-
New MDCG Guidance documents released
On 8 July 2024, the Medical Device Coordination Group (MDCG) issued an updated guidance to help manufacturers, notified bodies and health institutions classify in vitro diagnostic (IVD) devices before they are placed on the market under the In Vitro Diagnostic Regulation (IVDR).
-Read more-
